Main menu

SeqOne Genomics and the French CNR-MAT pioneer the use of Oxford Nanopore sequencing technology to improve outcomes in kidney disease while reducing turnaround times


SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies(CNR-MAT), aimed at improving outcomes in thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS), using Oxford Nanopore sequencing technology.

You can read the full announcement from SeqOne here.

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag